A polymorphism, rs78378222, in TP53, which encodes the tumor suppressor TP53 gene, is highly significant for BCC, with an overall OR of 2.16 (95% CI 1.83–2.54; p = 2.2 × 10−20). This evidence concerns the gene TP53 and skin basal cell carcinoma.